A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies

Condition:   Malignant Melanoma, NeoplasmsInterventions:   Drug: tizanidine;   Drug: vemurafenibSponsor:   Hoffmann-La RocheCompleted - verified May 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials